Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Charcot-Marie-tooth disease 1A (CMT1A) associated with a maternal duplication of chromosome 17p11.2-->12.
|
8500795 |
1993 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We describe here a CMT1 family (a 63-year-old man, his brother and his niece) in which two mutations on different chromosomes were found in the PMP22 gene, the 17p duplication, detected by fluorescent semiquantitative polymerase chain reaction (PCR) of microsatellite markers localized within the duplicated region on chromosome 17p11.2-p12, and the Thr(118)Met substitution, detected by direct sequencing the four coding exons of the PMP22 gene.
|
14502374 |
2003 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Genetic screening was performed for CMT cases (CMT1, CMT2, and hereditary neuropathy with susceptibility to pressure palsies [HNPP]).
|
28286897 |
2017 |
Charcot-Marie-Tooth Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
The fate of Schwann cells in Charcot-Marie-Tooth (CMT) neuropathies was addressed in this study of nerve biopsies from patients with proven PMP22 duplications and deletions.
|
9630241 |
1998 |
Charcot-Marie-Tooth Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
Pathomechanistic and therapeutic target advances in CMT include the identification of the ErbB receptor signalling pathway as a therapeutic target in CMT1A and pharmacological modification of the unfolded protein response in CMT1B.
|
27584852 |
2016 |
Charcot-Marie-Tooth Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
A subset of genomic disorders similarly characterized by CNVs between LCRs have been studied epidemiologically, including Williams-Beuren syndrome (7q11.23), Smith-Magenis syndrome (17p11.2), velocardiofacial syndrome (22q11.21), Prader-Willi/Angelman syndromes (15q11.2q12), 17q12 deletion syndrome, and Charcot-Marie-Tooth neuropathy type 1/hereditary neuropathy with liability to pressure palsy (PMP22, 17q11.2).
|
29691480 |
2018 |
Charcot-Marie-Tooth Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
Charcot-Marie-Tooth type 1A (CMT1A) is the most common type of hereditary motor and sensory neuropathies (HMSN), caused by the duplication of the 17p11.2 region that includes the PMP22 gene.
|
26479344 |
2016 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The most frequent form of Charcot-Marie-Tooth disease (CMT1A; OMIM118.220) is the result of a duplication on chromosome 17 in pll.2-p12.
|
8674184 |
1996 |
Charcot-Marie-Tooth Disease
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
In contrast, administration of the selective progesterone receptor antagonist reduced overexpression of Pmp22 and improved the CMT phenotype, without obvious side effects, in wild-type or transgenic rats.
|
14608378 |
2003 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
These results confirm the leading role of PMP22 mutation analysis in the differential diagnosis of CMT and show that the spectrum and frequency of PMP22 mutations in the Slovak population is comparable to that seen in the global population.
|
22131320 |
2011 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Thus, GJB1 mutation analysis should be done in patients without the PMP22 duplication and male-to-male transmission of CMT.
|
19691535 |
2009 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The most frequent genetic subtype of Charcot-Marie-Tooth disease is CMT1A, linked to chromosome 17p11.2.
|
16775377 |
2006 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
These observations highlight the wide spectrum of CMT1A and the overlap between CMT1A and HNPP (both linked to the PMP22 gene), and finally illustrate the complexity of the genotype-phenotype correlations in Charcot-Marie-Tooth diseases.
|
24792522 |
2014 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Recently, this has also been observed in mice mildly overexpressing human peripheral myelin protein 22 kD mimicking the most common form of CMT, CMT type 1A.
|
16775375 |
2006 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Charcot-Marie-Tooth disease 1A (CMT1A) is a hereditary demyelinating peripheral neuropathy, associated with a DNA duplication on chromosome 17p11.2.
|
1303231 |
1992 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations in three genes coding for the myelin proteins peripheral myelin protein 22, myelin protein zero and connexin 32 and in one gene coding for the transcription factor early growth response 2 element are associated with Charcot-Marie-Tooth type 1 and 2, hereditary neuropathy with liability to pressure palsies, Dejerine-Sottas syndrome and congenital hypomyelination.
|
10541586 |
1999 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We report on a 20-year-old male with severe Charcot-Marie-Tooth (CMT) disease and a de novo deletion (c.281delG, p.G94AfsX17) on the paternal PMP22 allele harboring c.353C>T (p.T118M).
|
19067730 |
2009 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Charcot-Marie-Tooth neuropathy type 1 (CMT1) is a genetically heterogeneous group of chronic demyelinating polyneuropathies with loci mapping to chromosome 17 (CMT1A), chromosome 1 (CMT1B), the X chromosome (CMTX) and to another unknown autosome (CMT1C).
|
7849745 |
1994 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Although more than seventy clinical and genetic forms are known to date, more than 80% of CMT patients in Western countries have genetic abnormalities associated with PMP22, MPZ, MFN2 and GJB1.
|
25454638 |
2014 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Linkage with the CMT loci already known (CMT1A, CMT1B, CMT2A, CMT2B, CMT2D, and a number of other CMT-related loci) was excluded.
|
10841809 |
2000 |
Charcot-Marie-Tooth Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
Charcot-Marie-Tooth 1A is caused by a duplication of PMP22 and further over-expression lead to a more severe disorder.
|
9021013 |
1997 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The epithelial membrane protein 3 gene, encoding a PMP22 homologous protein and located on 19q13.3, was ruled out as being responsible for this form of CMT.
|
11112660 |
2001 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
To determine the clinical consequences of the PMP22 point mutation, T118M, which has been previously considered to either cause an autosomal recessive form of Charcot-Marie-Tooth (CMT) disease or be a benign polymorphism.
|
16437560 |
2006 |
Charcot-Marie-Tooth Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A).
|
30650121 |
2019 |
Charcot-Marie-Tooth Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutants with 4 or 7 copies of the human PMP22 gene leading to a phenotype significantly close to CMT's disease type 1A were compared with control animals.
|
11328356 |
2001 |